NCT07559292
Implementing Artificial Intelligence to Prevent Vision Loss From Diabetes
Enrolling by Invitation
NAAges 22+InterventionalHealth servicesUniversity of Wisconsin, MadisonInvestigator-initiated
~1,700 participants
Updated 2026-04-30 on ClinicalTrials.gov
What's tested:AIUsual Practice
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of patients who get eye screening in the AI and usual-care arms within 5 months of the recommendation
Measured over up to 5 months
Conditions
Where it's being run
1 sites across 1 statesWisconsin1
Study leadership
- Roomsa Channa, MD · PRINCIPAL_INVESTIGATOR · University of Wisconsin, Madison
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Serve at least 267 patients with diabetes during the study period
No point-of-care screening system in use for diabetic eye disease
Agree to share limited identifiers data as requested
Age 22 years or older
Diagnosis of type 1 or 2 diabetes
No known diabetic eye disease
No diabetic eye exam in the past 12 months
Exclusion
Have a documented eye exam in the electronic health record within 12 months of the date of the primary care visit.
Contraindication includes diagnosed with macular edema, severe non-proliferative retinopathy, proliferative retinopathy, radiation retinopathy, or retinal vein occlusion.
Pregnant
What this trial measures
- Proportion of patients who get eye screening in the AI and usual-care arms within 5 months of the recommendationup to 5 months